Dogs could hold the key to a cure for cancer!!!!

Dogs could hold the key to a cure for cancer!!!!

  • (Photo) JAX received a $500,000 gift for the Tallwood Canine Cancer Research Initiative from an anonymous Hartford-area donor. The TCCRI project began in November 2017 with the collection of DNA from the first healthy canine sample – the donor family’s dog, Patrick, an Irish Wolfhound.

Please take a listen to this very exciting and informative interview with Dr Charles Lee of The Jackson Laboratory for Genomic Medicine! This study is ground-breaking and it's being done right here in Connecticut. Pet advocates be aware, this study does not do any unethical testing on animals, no manipulation of healthy pets. The pets used are with the owners and veterinarians consent after the tumors have been removed, but Dr Charles Lee will explain. This could actually lead to cancer cures/hope for not only humans but for pets too. I'm so honored to have met this man and will continue to keep you updated on this amazing study! #PeopleAndPets

  • (photo below) Dr. Charles Lee, Director and Professor at The Jackson Laboratory for Genomic Medicine (JAX), welcomes Patrick, a healthy Irish Wolfhound, to the campus of the nonprofit biomedical research institution’s Farmington, Conn. campus.

As Director and Professor at The Jackson Laboratory for Genomic Medicine (JAX), Dr. Lee is responsible for the scientific direction and coordination of the nonprofit, independent biomedical research institution.

Dr. Lee joined JAX Genomic Medicine from Harvard Medical School and Brigham and Women's Hospital. He is best known for his discovery that copy-number variation — a state in which cells have an abnormal number of DNA sections, sometimes associated with susceptibility or resistance to disease — is widespread and significant in the human genome. This discovery, and his subsequent research, has provided tools that clinicians use to help make accurate diagnoses for hundreds of thousands of genetic tests every year on conditions such as autism, birth defects and cancer.

Throughout his career, Dr. Lee has received numerous accolades and awards for his research into the human genome, including an Award from the American Association for Cancer Research and the 2008 Ho-Am Prize in Medicine. He is an elected fellow of the American Association for the Advancement of Science (AAAS), a 2014 Thompson Reuters Citation Laureate and is currently president of the Human Genome Organization (HUGO). In addition to his responsibilities at JAX Genomic Medicine, Dr. Lee is a distinguished professor at EWHA Womans University in Seoul, South Korea.


Content Goes Here